Planview Completes Acquisition of Tasktop
Planview, a global leader in Portfolio Management and Work Management solutions, today announced it has completed its acquisition of Tasktop, initially announced on May 18.
“Bringing Mik Kersten and the Tasktop team into Planview will help deliver new levels of excellence to companies and industries navigating through change,” said Razat Gaurav, CEO of Planview. “By merging Tasktop’s institutional expertise in scaling software with Planview’s focus on delivering enterprise-scale visibility, we’ve created a new industry powerhouse poised to help organizations connect the business of software delivery and conduct their business transformations with unprecedented confidence and efficiency.”
The combination of Planview and Tasktop means customers work with a single, comprehensive organization with cutting-edge expertise in capabilities ranging from Value Stream Management (VSM) to Strategic Portfolio Management and Enterprise Agile Planning, among others. At a time when organizations are navigating business transformations amid a turbulent macroeconomic landscape, having a single partner that provides intelligence and visibility into the progress of those transformations helps ensure success.
According to a May 2022 Forrester blog, The Market For VSM And SPM Takes A Big Step Forward, “We see the Planview + Tasktop combination having the potential to shake up the (Strategic Portfolio Management) SPM and VSM marketplace and force it to evolve at an even faster pace by putting pressure on existing leaders in agile planning and DevOps management solutions.”
“To succeed with digital transformation, organizations must expand beyond Agile teams to portfolio-level business agility,” said Dean Leffingwell, creator of SAFe® and cofounder, Scaled Agile, Inc. “We’re headed in the right direction. With so many enterprises now deploying SAFe, and the shift from project to product described in Mik Kersten’s book gaining mind share, this new way of working and thinking is finding its way into the CEO’s office. This new paradigm is helping leaders effectively connect the strategic portfolio level with software delivery, which introduces huge opportunities for the business. It is great to see our Scaled Agile partners Planview and Tasktop coming together to help enterprises maximize and accelerate those opportunities.”
The newly combined entity affirms Planview’s leading position globally with 4,500 enterprise customers worldwide, more than 1,300 employees, and a combined FY21 revenue of approximately $400 million. Planview will continue to invest in and support the Tasktop product lines as standalone solutions in the immediate term and will evaluate product direction long term based on customer and industry feedback. As part of the transaction, Tasktop cofounder and CEO, Mik Kersten, has joined Planview as Chief Technology Officer. You can read more about the Tasktop team’s go-forward focus in Mik’s blog.
Sumeru Equity Partners, Tasktop’s lead investor, along with minority investors Elsewhere Partners and Yaletown Partners, and Tasktop’s management will be rolling part of their equity in the new combined entity and will maintain minority interest in Planview alongside its majority shareholders, TPG and TA Associates. Golub Capital provided committed debt financing and Jefferies LLC acted as financial advisors to Planview. Ropes & Gray served as legal counsel to Planview. AGC Partners acted as financial advisors to Tasktop / Sumeru Equity Partners, and Kirkland & Ellis served as legal counsel.
About Planview
Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions create an organizational focus on the strategic outcomes that matter and empower teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220704005348/en/
Contact information
Leslie Marcotte
lmarcotte@planview.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 15:00:00 EET | Press release
Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations for treatment-resistant depression (TRD) from 10:00-11:30 am ET on January 7th. “PTSD is one of the most challenging mental health conditions, with approximately 13 million adults in the U.S. living with persistent symptoms and limited treatment options,” said Dr. Guy Goodwin, Chief Medical Officer at Compass Pathways. “We are pleased to advance our clinical development - the unmet need is profound, and it demands bold innovation. We believe COMP360 has the potential to tra
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 12:07:00 EET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release
I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom